What is the current stock price of Tricida, Inc. (TCDA)?

As of the latest market data, Tricida, Inc. (TCDA) is trading at $0.11. The stock has seen a loss of 0.00% today.

Does Tricida, Inc. (TCDA) pay a dividend?

Based on current data, Tricida, Inc. does not have a confirmed active dividend policy.

What is the market cap of Tricida, Inc.?

The current market capitalization of Tricida, Inc. (TCDA) is approximately unavailable.

TCDA

Tricida, Inc.·Healthcare

0.11

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0452W H: $13.85

Company Profile

Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2018-06-28

Beta

0.00

Websitewww.tricida.com↗